# Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal

> **NCT06906861** · — · COMPLETED · sponsor: **Institute of medicine, Maharagjung medical campus** · enrollment: 284 (actual)

## Conditions studied

- Epistaxis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06906861
- **Lead sponsor:** Institute of medicine, Maharagjung medical campus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2024-11-10
- **Final completion:** 2024-11-10
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06906861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06906861, "Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06906861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*